Nine-month interim r
Nine-month interim report (Q3) 2023
15 nov. 2023 01h30 HE | ALK Abello
ALK delivers 8% revenue growth with operating profit up 128% in Q3 (unaudited) ALK saw growth in all sales regions in Q3, led by sales of tablets and SCIT. As expected, European tablet sales...
Dato for offentliggø
Dato for offentliggørelse af delårsrapport for første ni måneder (Q3) 2023 for ALK og webcast
09 nov. 2023 07h46 HE | ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF) offentliggør delårsrapport for første ni måneder (Q3) 2023 onsdag den 15. november 2023. ALK afholder samme dag kl. 13.30 (CET) en telekonference for investorer...
Release date of nine
Release date of nine-month interim report (Q3) 2023 for ALK and audio cast
09 nov. 2023 07h46 HE | ALK Abello
On Wednesday, 15 November 2023 ALK (ALKB:DC / OMX: ALK B / AKBLF) releases its nine-month interim report (Q3) 2023. ALK will host a meeting for analysts and institutional investors that day at 1.30pm...
Stort klinisk fase 3
Stort klinisk fase 3-studie når sit primære endemål og bekræfter potentialet af ALK’s tabletvaccine mod træpollenallergi til børn
11 oct. 2023 10h13 HE | ALK Abello
Fase 3 effekt- og sikkerhedsstudiet med ALK’s tabletvaccine mod træpollenallergi omfattede 952 børn i alderen 5 til 17 år i Canada og EuropaALK har nu succesfuldt fuldført den kliniske udvikling af...
Large Phase 3 clinic
Large Phase 3 clinical trial successfully meets primary endpoint, confirming the potential of ALK’s tree tablet in children
11 oct. 2023 10h13 HE | ALK Abello
The Phase 3 efficacy and safety trial of ALK’s tree tablet involved 952 children aged 5 to 17 in Canada and Europe.ALK has now successfully completed pivotal clinical development for all five...
Six-month interim re
Six-month interim report (Q2) 2023
24 août 2023 01h30 HE | ALK Abello
Bemærk venligst, at rapporten udelukkende forefindes på engelsk ALK delivers 11% revenue growth with operating profit up 120% in Q2 (unaudited) ALK’s revenue grew by...
Six-month interim re
Six-month interim report (Q2) 2023
24 août 2023 01h30 HE | ALK Abello
ALK delivers 11% revenue growth with operating profit up 120% in Q2 (unaudited) ALK’s revenue grew by 11% in Q2 2023, driven by 17% growth in tablet sales and...
Dato for offentliggø
Dato for offentliggørelse af delårsrapport for første halvår (Q2) 2023 for ALK og webcast
18 août 2023 06h45 HE | ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF) offentliggør delårsrapport for første halvår (Q2) 2023 torsdag den 24. august 2023. ALK afholder samme dag kl. 13.30 (CEST) en telefonkonference for investorer og...
Release date of six-
Release date of six-month interim report (Q2) 2023 for ALK and audio cast
18 août 2023 06h45 HE | ALK Abello
On Thursday, 24 August 2023 ALK (ALKB:DC / OMX: ALK B / AKBLF) releases its six-month interim report (Q2) 2023. ALK will host a meeting for analysts and institutional investors that day at 1.30pm...
Administrerende dire
Administrerende direktør Carsten Hellmann fratræder ved udgangen af 2023. Peter Halling udpeget som hans efterfølger
19 juin 2023 02h40 HE | ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF) meddeler i dag, at Carsten Hellmann fratræder som administrerende direktør ved udgangen af 2023. Han efterfølges af Peter Halling senest den 1. januar 2024. ...